Zobrazeno 1 - 10
of 350
pro vyhledávání: '"Faricimab"'
Publikováno v:
BMC Ophthalmology, Vol 24, Iss 1, Pp 1-6 (2024)
Abstract Background This study aimed to compare the regressive effects of aflibercept and faricimab on pigment epithelial detachment (PED) in patients with neovascular age-related macular degeneration. Methods In total, 41 eyes of 40 patients diagnos
Externí odkaz:
https://doaj.org/article/2252f614eb1b45f3a7831b78feae0175
Publikováno v:
International Journal of Retina and Vitreous, Vol 10, Iss 1, Pp 1-11 (2024)
Abstract Background To systematically review the real-world outcomes of intravitreal faricimab treatment in patients with neovascular age-related macular degeneration (nAMD) to evaluate its efficacy and safety in clinical settings. This study was con
Externí odkaz:
https://doaj.org/article/ed620556cd564250adf9e91d90a8e471
Autor:
Ermete Giancipoli, Antonella Guglielmi, Anna Valeria Bux, Giulia Maria Emilia Clima, Francesco Pignatelli, Francesco Boscia, Pasquale Viggiano, Giacomo Boscia, Francesca Fortunato, Gianluca Besozzi, Alfredo Niro, Stefano Dore, Cristiana Iaculli
Publikováno v:
Ophthalmology and Therapy, Vol 13, Iss 8, Pp 2163-2184 (2024)
Abstract Introduction The aims of this work were to evaluate the real-world efficacy and safety of a loading dose of intravitreal faricimab in eyes with active neovascular age-related macular degeneration (n-AMD) or diabetic macular edema (DME) and t
Externí odkaz:
https://doaj.org/article/44b331a85ec34edd8a601ea598a68726
Publikováno v:
Ophthalmology and Therapy, Vol 13, Iss 8, Pp 2063-2066 (2024)
Abstract This is a summary of the original article ‟Cost‑Effectiveness of Faricimab in the Treatment of Diabetic Macular Oedema (DMO): A UK Analysis”. DMO, a serious eye condition that can lead to vision loss in people with diabetes, is a signi
Externí odkaz:
https://doaj.org/article/03c2c0b0de9f45fd8c4175f89e79f956
Autor:
Max Brinkmann, Pasquale Viggiano, Giacomo Boscia, Tom Müller, Niccolò Castellino, Jakob Schweighofer, Francesco Boscia, Mario Damiano Toro, Yosuf El-Shabrawi
Publikováno v:
Ophthalmology and Therapy, Vol 13, Iss 7, Pp 1981-1992 (2024)
Abstract Introduction To assess changes in choriocapillaris (CC) vascular density surrounding macular neovascularization (MNV) in treatment-naïve age-related macular degeneration (AMD) after faricimab application using optical coherence tomography a
Externí odkaz:
https://doaj.org/article/44fcd689829d4fa8a159d4d7c2263f13
Publikováno v:
Clinical Ophthalmology, Vol Volume 18, Pp 1479-1490 (2024)
Nicole QX Quah, Khawaja Muhammad Ammar Ali Javed, Lamees Arbi, Daren Hanumunthadu Department of Ophthalmology, Royal Free London NHS Foundation Trust, Royal Free Hospital, London, UKCorrespondence: Daren Hanumunthadu, Department of Ophthalmology, Roy
Externí odkaz:
https://doaj.org/article/1c4a3b915d74470ab9eb1a4ef3404240
Autor:
Ryo Mukai, Keiko Kataoka, Koji Tanaka, Yasunori Miyara, Ichiro Maruko, Makiko Nakayama, Yuto Watanabe, Akiko Yamamoto, Yu Wakatsuki, Hajime Onoe, Sorako Wakugawa, Nobuhiro Terao, Taiji Hasegawa, Moeko Kawai, Ruka Maruko, Kanako Itagaki, Jyunichiro Honjo, Annabelle A. Okada, Ryusaburo Mori, Hideki Koizumi, Tomohiro Iida, Tetsuju Sekiryu
Publikováno v:
Scientific Reports, Vol 14, Iss 1, Pp 1-12 (2024)
Abstract This multicentre retrospective study evaluated the 1-year outcomes and safety profile of faricimab in treatment-naïve patients with neovascular age-related macular degeneration (nAMD). Fifty-five patients (57 eyes) underwent loading therapy
Externí odkaz:
https://doaj.org/article/1edcbc6c44ce488aa2d1ba2c48567be8
Autor:
Hironori Takahashi, Satoru Inoda, Hidenori Takahashi, Ryota Takahashi, Yuto Hashimoto, Hana Yoshida, Hidetoshi Kawashima, Yasuo Yanagi
Publikováno v:
Scientific Reports, Vol 14, Iss 1, Pp 1-10 (2024)
Abstract This single-center retrospective cohort study analyzed the 1-year real-world treatment outcomes of 63 consecutive eyes (of 60 patients) with neovascular age-related macular degeneration (nAMD) that were switched from intravitreal brolucizuma
Externí odkaz:
https://doaj.org/article/ac7a826e8d464a38a4512c42b6439758
Autor:
Tanaka A, Hata M, Tsuchikawa M, Ueda-Arakawa NUA, Tamura H, Miyata M, Takahashi A, Kido A, Muraoka Y, Miyake M, Ooto S, Tsujikawa A
Publikováno v:
Clinical Ophthalmology, Vol Volume 18, Pp 507-516 (2024)
Asako Tanaka, Masayuki Hata, Memiri Tsuchikawa, Naoko Ueda-Arakawa Ueda-Arakawa, Hiroshi Tamura, Manabu Miyata, Ayako Takahashi, Ai Kido, Yuki Muraoka, Masahiro Miyake, Sotaro Ooto, Akitaka Tsujikawa Department of Ophthalmology and Visual Sciences, K
Externí odkaz:
https://doaj.org/article/136ff433eba54441a9dde18f43d9270b
Autor:
Fernando M Penha, Maliha Masud, Zoha A. Khanani, Mathew Thomas, Rodney D. Fong, Kyler Smith, Avishay Chand, Majid Khan, Greggory Gahn, Gustavo Barreto Melo, Arshad M. Khanani
Publikováno v:
International Journal of Retina and Vitreous, Vol 10, Iss 1, Pp 1-9 (2024)
Abstract Management of vitreoretinal disorders (e.g., neovascular age-related macular degeneration [nAMD] and diabetic macular edema [DME]) have assumed the standard therapy of lifelong anti-VEGF injections with drugs like aflibercept, brolucizumab,
Externí odkaz:
https://doaj.org/article/ae11d4baec3d46d4b4a667d73a6f4d9c